Welcome : Guest

Pelion S.A. (Poland) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Pelion S.A., which is principally a Healthcare Group. Illustrated with 179 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-09530
Price: $3500
Company Type: Public
Pages: 181
Date: January 2017
Market Data Tables: 179

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Pelion S.A.’s Sales by Product Segment Worldwide (2015) in Percentage for Marketing and Training Services, Lease of Property, Plant and Equipment, Services Under Cooperation Agreements, Logistics Services, Support and Advisory Services, and Other Services......3
Table 2: Pelion S.A.’s Sales by Geographic Region Worldwide (2015) in Percentage for Poland and Others......4
Healthcare Institutions......5
Table 3: Healthcare Institutions Market by Category in China (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Primary Healthcare Clinics and Others......5
Healthcare Services......6
Table 4: Health Services Market by Segment in Canada (2015) - Percentage Share Breakdown by Value for Drugs, Hospitals, Physicians, and Others......6
Table 5: Healthcare Service Provider System Market by Type in China (2015) - Percentage Share Breakdown by Value for Hospitals, Primary Healthcare Clinics and Others......7
Table 6: Healthcare Services Market by Segment in the US (2015) - Percentage Share Breakdown by Value for For Profit Hospitals and Others......8
Acne Drugs......9
Table 7: Acne Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Isotretinoin, Topicals (Retinoid/Antibiotics), Oral Antibiotics, and Others......9
Table 8: Anti-acne Topical Dermatology Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Acne, AK + Psoriasis + Dermatitis + Others, Anti-Fungal Combo, Anti-Infective, Coagulants, Corticosteroids Combo, and Corticosteroids Plain......10
Table 9: Acne Drugs Market by Segments in the US (2015) - Percentage Share Breakdown by Volume for Orals and Topicals......11
Allergy Drugs......12
Table 10: Allergy and Rhinitis Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Allegra and Telfast, Avamys and Veramyst, Claritin and Clarinex, Zyrtec and Xyzal, and Others......12
Table 11: Allergy Care Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others......13
Table 12: US Market (Private Label and Others) by Product (2015) - Percentage Share Breakdown by Values Sales for Allergy Care, Baby Food, Bakery, Bleach, Dairy, Deodorants, Hair Care, Ice Cream, Laundry Care, Oral Care, OTC, Pet Food, Pet Products, Retail Tissue, Sauces/Dressing, Skin Care, Sun Care, Toilet Care and VDS......14
Antihypertensive Drugs......15
Table 13: Antihypertensive Drugs Market by Product in China (2105) - Percentage Share Breakdown by Value for Angiotensin II Receptor Blockers (ARBs), Beta Blocker, Calcium Channel Blocker and Others......15
Table 14: Hypertension Treatment Market by Segment in China (2015) - Percentage Share Breakdown by Value for Products to Regulate Blood Lipid Levels, and Products to Regulate Blood Sugar......16
Asthma Drugs......17
Table 15: Asthma Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......17
Table 16: No. of Asthma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......18
Table 17: Asthma Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Advair Diskus, Combivent, Proair HFA, Singulair, Spiriva HandiHaler, Symbicort, and Others......19
Bone Disease Drugs......20
Table 18: Bone Disease Drugs Market by Therapy Worldwide (2015) - Percentage Share Breakdown by Value Sales for Bisphosphonates, Bone Oncology, Hormonal Agents, SERMS, and Others......20
Buprenorphine and Naloxone Drugs......21
Table 19: Buprenorphine and Naloxone Drugs Market by Payers Worldwide (2015) - Percentage Share Breakdown by Value for Assistance Programmes, Commercial, Medicaid and Others......21
Cancer Drugs......22
Table 20: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......22
Table 21: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......23
Depression Drugs......24
Table 22: Depression Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Bupropion Hydrochloride XL, Cymbalta, Escitalopram Oxalate, Lexapro, Pristiq, and Others......24
Dermatological Drugs......25
Table 23: Dermatological Drug Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Acne, Alopecia, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Skin Cancer, and Skin Infections......25
Table 24: Dermatology Drugs Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......26
Table 25: Dermatology Market by Category in the US (2015) - Percentage Share Breakdown by Value for Genericised, Off-Patent but No Generics, On-Patent, and Others......27
Table 26: Dermal Substitutes Chronic Wound Market by Category in the US (2015) - Percentage Share Breakdown by Value for Diabetic Foot Ulcer, Pressure Ulcer and Venous Leg Ulcer......28
Table 27: Prevalence & Severity of Actinic Keratoses Market by Category in the US (2015) - Percentage Share Breakdown by Value for Minimal, Moderate, Severe, and Others......29
Drugs......30
Table 28: Drugs Market by Region Worldwide (2015) - Percentage share Breakdown by Value Sales for Switzerland, US, Others Europe, and Rest of World......30
Table 29: Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Specialty Drugs, and Traditional Oral Drugs......31
Table 30: Spending on Drugs by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Canada, European Union, Japan, South Korea, US, and Others......32
Table 31: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......33
Table 32: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Brand, Generic and Other......34
Table 33: Drugs Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value for Biotechnology, Conventional and Other Unclassified......35
Table 34: Spending on Medicines by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia, Australia, Europe, Latin America, North America, and others......36
Table 35: Drug Market by Category in Asia-Pacific (2015) - Percentage Share Breakdown by Value Sales for Branded Generics, Originals and Un-Branded Generics......37
Table 36: Government Spending on Drugs by Category in Australia (2015) - Percentage Market Share Breakdown by Sales for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......38
Table 37: Government Spending on Drugs by Category in Australia (2015) - Percentage Market Share Breakdown by Volume for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......39
Table 38: Drugs Market by Category in Brazil (2015) - Percentage Share Breakdown by Volume for Generics and Others......40
Table 39: Drug Distribution Expenditure by Category in Canada (2015) - Percentage Share Breakdown by Value for Out of Pocket, Private Insurers and Public Payers......41
Table 40: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Medical Devices, Over-the-counter Drugs, Prescription Drugs, Traditional Chinese Medicine, and Others......42
Table 41: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Finished Drugs and Intermediate and Bulk Medicine......43
Table 42: Hospital Drug Market by Segment in China (2015) - Percentage Share Breakdown by Value for Anti-Infection, Cardio-Cerebral Vascular, Digest, Neurology, Oncology and Others......44
Table 43: Finished Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Antihypertensive Drugs, Digestive System Drugs, Liver Drugs and Others......45
Table 44: Patent Medicines Sales by Drugs in China (2015) - Percentage Share Breakdown by Value for Cardio-Cerebrovascular Drugs, Digestive System Drugs, Drugs for Deoplastic Diseases, Gynecological Drugs, Musculoskeletal Drugs, Nervous System Drugs, Respiratory System Drugs, Urinary System Drugs and Others......46
Table 45: Drugs Market by Category in France (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......47
Table 46: Formulations Sales by Category in India (2015) - Percentage Market Share Breakdown by Value for Anti Infective, Anti-diabetic, Central Nervous System (CNS), Cyclic Vomiting Syndrome (CVS), Gastrointestinal, Pain Management, and Others......48
Table 47: Drugs Market by Sector in Greece (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......49
Table 48: Ethical Drugs Revenues by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generic, Licensed and Unbranded Generic......50
Table 49: Drugs Market by Category in Italy (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......51
Table 50: Drugs Market by Category in Singapore (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......52
Table 51: Prescription Drugs Market in the US (2014) in US$ Million......53
Table 52: Critical Shortage Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Injectable, Orals, and Others......54
Table 53: Critical Shortage Drugs Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Anti-Infectives, Central Nervous System (CNS), Oncology, Pain, Vitamins and Minerals, and Others......55
Table 54: Critical Shortage Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Brand, Branded Generic, Generic, and Other Branded Generic......56
Table 55: Spending on Drugs by Category in the US (2015) - Percentage Share Breakdown by Value for Specialty Drugs and Traditional Drugs......57
Table 56: Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for Non-specialty and Specialty......58
Table 57: Drugs Sales by Type in the US (2015) - Percentage Share Breakdown by Value for Cefdinir, Cephalexin, Cofactor and Others......59
Table 58: A-2 Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Generic Doxycycline, Generic Minocycline, Generic Tetracycline, and Others......60
Table 59: Spending on Medicines by Category in the US (2015) - Percentage Share Breakdown by Value for Specialty Pharmaceuticals and Traditional Pharmaceuticals......61
Table 60: Spending on Medicines by Product in the US (2015) - Percentage Share Breakdown by Value for Injectable, Oral and Other Forms......62
Table 61: Spending on Medicines by Segment in the US (2015) - Percentage Share Breakdown by Value for Biologics and Small-Molecules......63
Table 62: Spending on Medicines by Source in the US (2015) - Percentage Share Breakdown by Value for Non-Retail and Retail......64
Table 63: Spending on Medicines by Type in the US (2015) - Percentage Share Breakdown by Value for Branded Generics, Brands and Unbranded Generics......65
Drugs of Abuse Testing (DOA) Testing......66
Table 64: Drugs of Abuse Testing (DOA) Testing by Technology Worldwide (2015) - Percentage Market Share Breakdown by Value for Heterogeneous, Homogenous, and POC/Rapid......66
Epilepsy Drugs......67
Table 65: Epilepsy Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......67
Gastroesophageal Reflux Disease (GERD) Drugs......68
Table 66: Gastroesophageal Reflux Disease (GERD) Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Aciphex, Dexiant, Lansporazole, Nexium, Omeprazole, and Others......68
Gastrointestinal Drugs......69
Table 67: Gastrointestinal Market Worldwide (2015) in US$ Million......69
Table 68: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......70
Generic Drugs......71
Table 69: Generics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America, Russia and Other CIS and Rest of the World......71
Table 70: Generic Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......72
Glaucoma Drugs......73
Table 71: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......73
Inflammatory Bowel Disease (IBD) Drugs......74
Table 72: Inflammatory Bowel Disease (IBD) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Inflammatory, Biologics, and Immunomodulatory......74
Infectious Disease Drugs......75
Table 73: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......75
Table 74: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......76
Kidney Disease Drugs......77
Table 75: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2015) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......77
Table 76: Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......78
Table 77: Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, EPO alfa/beta biosimilars and Others......79
Table 78: Hemodialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others......80
Table 79: Chronic Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......81
Table 80: Peritoneal Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Includes Mircera)......82
Table 81: New Patients with Kidney Failure by Cause in the US (2015) - Percentage Share Breakdown by Volume for Diabetes, High Blood Pressure and Others......83
Lipid-Lowering Drugs......84
Table 82: Lipid-Lowering Drug Market by Product Category China (2015) - Percentage Share Breakdown by Value for Statins, Xuezhikang, and Other Products......84
Migraine Drugs......85
Table 83: Migraine Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Prescriptions for Amerge Generic (Naratriptan), Imitrex Generic (Sumatriptan), Maxalt Generic (Rizatriptan), Relpax (Pfizer), and Zomig Generic (Zolmitriptan)......85
Narcotic Drugs......86
Table 84: Narcotic Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value Sales for Butorphanol, Daphine Giraldii Nitsche, Dihydrocodeine/Paracetamol and dihydrocodeine, Fentanyl, Morphine, Oxycodone Acetaminophen, Tramadol, and Others......86
Table 85: Narcotic Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Morphine, Oxycodone, Tramadol and Others......87
Non-Stimulant Drugs......88
Table 86: Non-Stimulant Drugs Market by Prescription Worldwide (2015) - Percentage Share Breakdown by Value for Intunniv, Kapvay, and Strattera......88
Ophthalmic Drugs......89
Table 87: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......89
Table 88: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......90
Respiratory Drugs......91
Table 89: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......91
Table 90: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......92
Over the Counter (OTC) Drugs......93
Table 91: OTC Market (Private Label and Others) by Region Worldwide (2015) - Percentage Share Breakdown by Values Sales for Australia, Canada, Chile, France, Germany, Israel, Japan, Netherlands, Russia, United Kingdom, USA and Rest of the World......93
Table 92: OTC Drug Sales by Category in China (2015) - Percentage Market Share Breakdown by Value for Anti-Inflammatory, Cold, Gastrointestinal, Gynecological, Minerals, Tonics, Vitamins, Supplements, and Others......94
Table 93: OTC Drugs Market by Channel in China (2015) - Percentage Share Breakdown by Value Sales for Clinics, Community Hospital, General Hospital, Pharmacy, Supermarket, and Others......95
Table 94: Over - The - Counter (OTC) Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for Cough, Cold, Allergy & Sinus, Digestives,......96
Pain Relief, Vitamins & Supplements, Weight Loss & Nutritional Meal Replacements and Others
Pain Drugs......97
Table 95: Pain Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Hydrocordone, Acetaminophen, Lidoderm, Lyrica, OpanaER, Oxycotin, and Others......97
Rheumatology Drugs......98
Table 96: Rheumatology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biologicals, Coxibs, NSAIDs, TNF Inhibitors, and Others......98
Table 97: Rheumatology Drugs Market by Product Type in the US (2015) - Percentage Share Breakdown by Value Sales for Biologicals/TNF Inhibitors, Coxibs, DMARDS, Gout, MuscleRelaxants, NSAIDS, and Others......99
Special Treatment Drugs......100
Table 98: Special Treatment Drugs Market by Group in Vietnam (2015) - Percentage Share Breakdown by Value for Cardiovascular Group, Metabolism Group, Neurology, Sterilization Group and Others......100
Specialty Pharma & Orphan Drugs......101
Table 99: Specialty Pharma & Orphan Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, US and Rest of the World......101
Stimulant Drugs (Branded)......102
Table 100: Branded Stimulant Drugs Market by Prescription Worldwide (2015) - Percentage Share Breakdown by Value for Adderall XR, Focalin XR, Vyvanse and Others......102
Stroke Drugs......103
Table 101: Market Shares of Leading Stroke Drugs Brands in China (2015) - Percentage Share Breakdown by Value for Aodejin, Oudimei, Shenjie, Xueshuanto, and Others......103
Therapeutic Drugs......104
Table 102: Therapeutic Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......104
Ulcer Drugs......105
Table 103: Ulcer Drugs by Category in the US (2015) - Percentage Share Breakdown by Number of Prescriptions for H2 Blockers, Proton Pump Inhibitors, and Others......105
Urinary Incontinence Drugs......106
Table 104: Urinary Incontinence Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......106
Table 105: Urinary Incontinence Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......107
Women's Health Drugs......108
Table 106: Women's Health Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Contraceptives, Hormone Therapy, Fertility, and Others......108
Healthcare Services......109
Table 107: Market Shares of Leading Health Care Service Providers in the US (2015) - Percentage Breakdown by Purchasing Volume for Amerinet, Inc., HealthTrust, LLC, MedAssets, Inc., Novation, LLC, Premier Healthcare, LLC, and Others......109
Health Plans (Private)......110
Table 108: Market Shares of Leading Private Health Plan Providers by Value Sales in Brazil (2014) - Percentage Breakdown for Bradesco Saude S/A, Golden Cross Health Care, Hapvida Health System, Intermédica Health System S/A, Porto Seguro S.A., Sul América S.A., Unimed Medical Supplies, Inc., United Health Group, and Others......110
Acne Drugs......111
Table 109: Market Shares of Leading Branded Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Allergan, Inc., Galderma, Valeant Pharmaceuticals International, Inc. and Others......111
Table 110: Market Shares of Leading Branded Anti-acne Treatement Providers Worldwide (2015) - Percentage Share Breakdown by Value for Allergan, plc, Bayer AG, Galderma S.A., GlaxoSmithKline Pharmaceuticals Ltd., Prasco Laboratories, Valeant Pharmaceuticals International, Inc., and Others......112
Table 111: Market Shares of Leading Generic Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan, Perrigo Company, Pfizer, Inc., Sandoz and Others......113
Table 112: Market Shares of Leading Generic Anti-acne Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan N.V., Perrigo Company plc, Pfizer, Inc., Prasco Laboratories, Rouses Point Pharmaceuticals LLC, Sandoz Inc., Taro Pharmaceutical Industries Ltd., and Private Label......114
Table 113: Topical Prescription Acne Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Cash Payment, Commercial, and Managed Medicaid Payment, Medicare Payment......115
Table 114: Market Shares of Leading Topical Acne Treatment Brands in the US (2015) - Percentage Market Share Breakdown by Volume for Acanya, Aczone, Differin, Epiduo, Finacea, and Others......116
Table 115: Oral Prescription Acne Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Cash Payment, Commercial, and Medicare Payment......117
Table 116: Market Shares of Leading Oral Acne Treatment Brands in the US (2015) - Percentage Market Share Breakdown by Volume for Doryx, Monodox, Oracea, Solodyn, and Others......118
Alzheimer's Disease Drugs......119
Table 117: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......119
Table 118: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......120
Analgesics Capsule Drugs......121
Table 119: Market Shares of Leading Drug (Analgesics Capsule) Companies in China (2015) - Percentage Breakdown by Value for Beijing Novartis Pharma Ltd., GlaxoSmithKline (Tianjin) Co., Ltd., Tibet Cheezheng Tibetan Medicine Company Ltd., Yunnan Baiyao Group, and Others......121
Antihypertensive Drugs......122
Table 120: Market Shares of Leading Antihypertensive Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for AstraZeneca, Bayer AG, Novartis International AG, Pfizer, Inc., Sanofi-Aventis and Others......122
Cancer Drugs......123
Table 121: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......123
Table 122: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......124
Table 123: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......125
Table 124: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......126
Table 125: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......127
Breast Cancer Drugs......128
Table 126: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......128
Cardio-Cerebral Vascular (CCV) Drugs......129
Table 127: Market Shares of Leading Cardio-Cerebral Vascular (CCV) Drugs Manufacturers in China (2015) - Percentage Share Breakdown by Value for Sihuan Pharmaceutical Holdings Group Ltd., Sanofi S.A., Qilu pharmaceutical Co., Ltd. and Others......129
Diabetes Drugs......130
Table 128: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......130
Table 129: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......131
Table 130: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......132
Diclofenac Drugs......133
Table 131: Diclofenac Drug Market by Product in China (2015) - Percentage Share Breakdown by Value for Difene (Temmler Werke), Votalin (Novartis), Yingtaiqing (Simcere) and Others......133
Drugs......134
Table 132: Market Shares of Leading Drug Distributors Worldwide (2014) - Percentage Breakdown by Value for AmerisourceBergen Corporation, Express Scripts, McKesson Corporation, Metro Medical and Others......134
Table 133: Market Shares of Leading Drug Providers in the US (2014) - Percentage Breakdown by Value for Clearwater Paper Corporation and Other Private Label......135
Table 134: Market Shares of Leading Domestic Drugs Manufacturers in Vietnam (2015) - Percentage Share Breakdown by Volume for DHG Pharmaceutical JSC, Traphaco Joint Stock Company and Others......136
Erectile Dysfunction Drugs......137
Table 135: Market Shares of Leading Erectile Dysfunction Drugs Brands in the US (2015) - Percentage Breakdown by Value for Cialis, Viagra, and Others......137
Table 136: Market Shares of Leading Erectile Dysfunction (ED) Drug Brands by Value Sales in Korea (2014) - Percentage Breakdown for Cialis, Levitra, Mvix, Viagra, Yaila, and Zydena......138
Female Hormone Drugs......139
Table 137: Market Shares of Leading Female Hormone Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Naturalendo, Novo Nordisk, Pfizer, Inc., Warner Chilcott and Others......139
Fertility Drugs......140
Table 138: Market Shares of Leading Fertility Drugs Manufacturing Companies in China (2015) - Percentage Share Breakdown by Value for AstraZeneca (International), GeneScience Pharmaceutical Co., Ltd. (Domestic), Ipsen Pharma (International), Livzon Pharmaceutical Group Co., Ltd. (Domestic), Merck Serono (International) and Others......140
Gastrointestinal Drugs......141
Table 139: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......141
Table 140: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......142
Table 141: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over- the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......143
Table 142: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......144
Table 143: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......145
Gaucher Disease Drugs......146
Table 144: Market Shares of Drugs for Gaucher Disease by Region Worldwide (2014) - Percentage Breakdown by Value for European Union, United States and Rest of World......146
Table 145: Market Shares of Leading Drugs for Gaucher Disease Worldwide (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......147
Table 146: Market Shares of Leading Drugs for Gaucher Disease in Brazil (2015) - Percentage Share Breakdown by Value for Cerezyme, Eliglustat and Others......148
Table 147: Market Shares of Leading Drugs for Gaucher Disease in EU (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......149
Table 148: Market Shares of Leading Drugs for Gaucher Disease in the US (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......150
IV Generic Drugs......151
Table 149: Market Shares of Leading IV Generic Drugs Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Baxter International, Inc., Fresenius Kabi AG, Hospira, Inc., Novartis International AG, Sun Pharmaceutical Industries Limited and Others......151
GLP-1 based Drugs......152
Table 150: Market Shares of Leading Drug Sales for GLP-1 based Diabetes Worldwide (2014) - Percentage Breakdown by Value for Albilgutide, Bydureon, Byetta, Dulaglutide, Lixumia and Victoza......152
Table 151: GLP-1 Sales by Category in the US (2015) - Percentage Market Share Breakdown by Value for Byetta/Bydureon (AZN), Lixisenatide (SNY), and Victoza (NovoNordisk)......153
Gonadotropic Drugs......154
Table 152: Market Shares of Leading Gonadotropic Drug Manufacturing Companies in China (2015) - Percentage Share Breakdown by Value for Livzon (Domestic), IBSA Institut Biochimique (International) and Merck Serono (International)......154
Hepatitis B Drugs......155
Table 153: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......155
Table 154: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......156
HIV Drugs......157
Table 155: HIV Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)/ Nucleoside Reverse Transcriptase Inhibitor (NRTI) Fixed Dose Combination (FDC), Nucleoside Reverse Transcriptase Inhibitor (NRTI)/Retroviral Integrase/CYP3A, Nucleoside Reverse Transcriptase Inhibitor (NRTIs), Protease Inhibitors, Retroviral Integrase (IN), and Others* (Includes NNRTIs)......157
Table 156: HIV Regimens for New Start Patients by Segment in European Union (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......158
Table 157: HIV Regimens for Experienced Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Stribild, Truvada and Others......159
Table 158: HIV Regimens for New Start Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......160
Imi-Cila Drugs......161
Table 159: Imi-Cila Drug Sales by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for European Union, US and Rest of World......161
Infectious Disease Drugs......162
Table 160: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......162
Injectable Drugs......163
Table 161: Market Shares of Leading Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co. KGaA, Hospira, Inc., Novartis AG, Pfizer, Inc., West-Ward Pharmaceuticals Corporation, and Others......163
Table 162: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others......164
Table 163: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......165
Table 164: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......166
Table 165: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......167
Table 166: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......168
Table 167: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......169
Table 168: Market Shares of Leading Injectable Miotics Manufacturers in the US (2015) - Percentage Breakdown by Value for Alcon Incorporated, and Novartis International AG......170
Insomnia Drugs......171
Table 169: Market Shares of Leading Insomnia Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Jazz Pharmaceuticals (JAZZ), Sanofi S.A. (SNY), Somaxon Pharmaceuticals, Inc. (SOMX), Takeda Pharmaceutical Company Limited, Generics, and Others......171
Narcotic Drugs......172
Table 170: Market Shares of Leading Narcotic Drugs Manufacturers by Value Sales in China (2014) - Percentage Breakdown for Beijing Mundipharma Ltd., China National Medicines Corporation, Impofstoffwerk Dessau Tomau GmbH, Notheast Pharmaceutical Group ., Ltd., Shanhaiguan Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., The Grunenthal Group, Weihal Lotus Pharmaceutical Co., Ltd., Wuhan HumanWell Bi-Tech Industry Co., Ltd., Xian-Janseen Pharmaceutical Ltd., and Others......172
Phosphate Binder Drugs......173
Table 171: Market Shares of Leading Phosphate Binder Drugs for Treatment of Hyperkalemia and Hyperphosphatemia Worldwide (2015) - Percentage Share Breakdown by Value for Calcium Acetate, Sevelamer and Others......173
Post-Traumatic Stress Disorder (PTSD) Drugs......174
Table 172: Market Shares of Leading Drugs for Post-Traumatic Stress Disorder (PTSD) Treatment in the US (2015) - Percentage Share Breakdown by Value for Citalopram, Clonazepam, Escitalopram, Quetiapine, Quetiapine, Sertraline, and Others......174
Linezolid Drugs......175
Table 173: Linezolid Drug Market by Category in the US (2015) - Percentage Share Breakdown by Value for Hospital and Others......175
Meropenem Drugs......176
Table 174: Meropenem Drug Sales by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for European Union, US and Rest of World......176
MRSA Drugs......177
Table 175: MRSA Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value Sales for Cubicin, Semi-Synthetics/SYNERCID, Tygacil, Vancomycin, Zyvox IV, and Zyvox Oral......177
Ophthalmology Drugs......178
Table 176: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......178
Table 177: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......179
Table 178: Pelion S.A.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Poland and Others......180
Table 179: Pelion S.A.’s (Operations) Sales by Product Segment Worldwide (2013-2014) in percentage for Marketing and Training Services, Lease of Property, Plant and Equipment, Services Under Cooperation Agreements, Telecommunications and Hotline Services, Logistics Services, IT Services, Support and Advisory Services, Agency Services and Other Services......181